Background
==========

Considerable attention is currently being focused on the genotyping of single nucleotide polymorphisms (SNPs) to search for complex disease susceptibility alleles. The success to detect association between marker alleles and disease critically depends on the extent of linkage disequilibrium (LD) between functional alleles and surrounding markers. Studies on some chromosomes and genome regions have shown that LD is highly variable across human genome and is structured into discrete blocks of sequences separated by hotspots of recombination and/or LD breakdown \[[@B1]-[@B6]\]. The LD heterogeneity across the genome is a crucial aspect for genome-wide association studies, which has been emphasized as a powerful approach for complex disease study \[[@B7]-[@B9]\]. Due to practical limitations of the expenses, the sample size used on the whole genome scale may not be sufficiently large. For example, the ongoing HapMap represents one of the most comprehensive and largest efforts ever attempted in biomedical research, in which a total of 270 subjects from African, Caucasian and Japanese/Chinese were recruited. However, sample size is an important factor influencing the accuracy of LD evaluation. Small sample size will bias the accuracy of LD estimation \[[@B2],[@B10]\].

A limited but hypothesis-driven approach for association studies is to focus on the polymorphisms located in or around the candidate genes known to be of potentially functional importance for complex traits (based on their cellular and molecular studies). LD patterns in specific candidate genes need be empirically assessed to facilitate efficient experimental designs and execution of association studies \[[@B1],[@B11]\]. So far, only limited information is available about the LD patterns and haplotype characteristics in candidate genes for complex diseases \[[@B12],[@B13]\].

The purpose of this study was to determine the LD and haplotype characteristics in eight candidate genes for the two common complex disorders, osteoporosis and obesity. These eight genes are apolipoprotein E (APOE), type I collagen α1 (COL1A1), estrogen receptor-α (ER-α), leptin receptor (LEPR), parathyroid hormone (PTH)/PTH-related peptide receptor type 1 (PTHR1), transforming growth factor-β1 (TGF-β1), uncoupling protein 3 (UCP3), and vitamin D (1,25-dihydroxyvitamin D~3~) receptor (VDR).

Results
=======

Haplotype analysis
------------------

Allele frequencies of the 31 SNPs are shown in Table [1](#T1){ref-type="table"}. The information for the main haplotypes whose frequencies were higher than 1% \[[@B14]\], is presented in Table [2](#T2){ref-type="table"}. It is clear that the number of observed haplotypes was smaller than that of haplotypes expected. The number of observed haplotypes varied at different loci. In both the PTHR1 gene and the VDR gene, four SNPs were studied. However, seven and twelve haplotypes, respectively, were observed as compared to the expected 16 haplotypes in each gene.

###### 

Information about the 37 SNPs in the eight genes

  SNP   Gene     dbSNP accession   polymor phism^a^   Domain      Distance^b^   Frequency (%)^c^   Forward Primer                   Reverse Primer
  ----- -------- ----------------- ------------------ ----------- ------------- ------------------ -------------------------------- --------------------------------
  1     APOE     ss12568587        G-*C*              5\' UTR                   35.7               TCCCCAGGAGCCGGTGA                CCCCAAGCCCGACCCC
  2     APOE     ss12568609        G-*A*              Intron 2    1,277         39.9               CCTCAGGTGATCTGCCCGTTTC           ACTCCTGGGCTCAAGTGATCCTC
  3     APOE     ss12568607        T-*C*              Exon 4      1,497         14.9               CGGGCACGGCTGTCCAA                CGAGCATGGCCTGCACCTC
  4     APOE     ss12568612        C-*T*              Exon 4      138           8.7                GCTGCGTAAGCGGCTCC                GCGGCCCTGTTCCACC
  5     COL1A1   ss12568606        G-*T*              5\' UTR                   15.4               GCACCCTGCCCTAGACCAC              CCTAGTGCCAGCGACTGCA
  6     COL1A1   ss12568597        G-*T*              Intron 1    3,543         18.8               CCAATCAGCCGCTCCCATTC             CATCGGGAGGGCAGGCTC
  7     COL1A1   ss12568598        G-*T*              Exon 8      2,365         0.0                GGAAGACTGGGATGAGGGCA             GGCTCGCCAGGCTCACC
  8     COL1A1   ss12568584        G-*A*              Exon 45     9,862         1.9                CTCAGCCTTCCCTGGCCAA              AGGCGGAAGTTCCATTGGCATC
  9     ER-α     ss12568579        A-*G*              Exon 1                    48.4               TTGAGCTGCGGACGGTTCA              CGCCGGTTTCTGAGCCTTC
  10    ER-α     ss12568596        T-*C*              Intron 1    34,258        44.9               TGGGATTCCAGGCATGAACCAC           TGGCGTCGATTATCTGAATTTGGCC
  11    ER-α     ss12568619        G-*A*              Intron 3    66,110        25.7               CCCAGAAACAAGTCATCTGCTATTGACA     GTAACAAAAGGTTAACAATGGTTAGCCC
  12    ER-α     ss12568618        G-*C*              Exon 4      36,077        21.8               ACAGCCTGGCCTTGTCCC               CAGGTTGGTCAGTAAGCCCATCA
  13    ER-α     ss12568585        G-*A*              Intron 4    39,074        9.8                GATCAATGAAGTGGGTCTTGAAAAACCAA    GGTGACAAGCTGGAAATCTAAGCTTCA
  14    ER-α     ss12568605        G-*A*              Intron 6    83,068        11.9               GGAACGGCCCTTGGAAATTGTAAA         CTGCCTACAGAATACAGTCAGCCA
  15    ER-α     ss12568617        G-*A*              Exon 8      32,431        20.3               TCGCATTCCTTGCAAAAGTATTACATCAC    CAAGCAAATGAATGGCCACTCATCTAGAAA
  16    LEPR     ss12568615        A-*G*              Exon 4                    29.0               AGATTTAAGTTGTCTTGCATGCCACC       TTAAGCCCAGCATCCATTAGCTATTCTTTC
  17    LEPR     ss12568604        G-*C*              Exon 14     3,013         18.2               GAGTAATTGGAGCAATCCAGCCTACA       GCTTCAGCCACTGTACATCTTAGCTC
  18    LEPR     ss12568614        G-*A*              Exon 20     62,803        35.3               GCCACGCTGATCAGCAACTC             CCCTTGACTTGTCAGTCAAAAGCAC
  19    PTHR1    ss12568589        G-*A*              Intron 1                  0.1                GACTTACATTAGGATTCAAGGTTACTGCCA   GGGACGCAAGCCTGAGTCC
  20    PTHR1    ss12568592        A-*G*              Intron 2    4,250         39.8               GCAGAACCCTAAGGGCTTGTCA           GGCGGGACCCAGGATACA
  21    PTHR1    ss12568591        C-*T*              Intron 8    5,436         37.4               CGAGCCTCAATTCAGGTGAATCTAACC      CCCGCCCCAAGTGGAACA
  22    PTHR1    ss12568588        G-*A*              Intron 10   1,912         39.7               CCTTGAGCCCTTGGTTTTCCTTTC         GCTCCGGGAACAAAAAGTGGATCA
  23    PTHR1    ss12568590        G-*A*              Exon 13     1,246         38.0               CTACAAGGCTCAAATTGCCCCAAA         TTGGCGTCCACTACATTGTCTTCA
  24    TGF-β1   ss12568613        C-*T*              5\' UTR                   31.1               GGGCCCAGTTTCCCTATCTGTAAA         CTGGGCCACCGTCCTCATC
  25    TGF-β1   ss12568603        +C/*-C*            Intron 4    12,354        2.1                CCACGCCCCACTTATCTATCCC           GGAAAGGCCGGTTCATGCCA
  26    TGF-β1   ss12568593        C-*T*              Exon 5      83            0.8                CAGGCTACAAGGCTCACCTGAA           GGTTCACTACCGGCCGC
  27    TGF-β1   ss12568602        C-*T*              Intron 5    9,644         27.4               GGCTTGTCTTAAGCATTGCGTGAAATTAA    GTACAGCTGCCGCACGC
  28    UCP3     ss12568601        C-*T*              5\' UTR                   26.5               CACTGCCCTCACCAGCCA               GTGAGTCCTGCCACGGCA
  29    UCP3     ss12568600        G-*A*              Exon 2      2,122         0.0                GCCCTAAAGGGACTGGGCA              GAAAGGTAACGAGGTCAGCAAAACA
  30    UCP3     ss12568595        T-*C*              Exon 3      809           25.8               TGATTCCCGTAACATCTGGACTTTCATC     CTGCCTAAATCCCCTTAGCAGAAAAAAAAA
  31    UCP3     ss12568580        T-*C*              Exon 5      1,712         44.7               CCTAACAGGAACTTTGCCCAACATCA       TCCACGGAGTTCTGGGTTCC
  32    UCP3     ss12568599        C-*T*              Exon 7      2,996         0.0                CCTAACAGGAACTTTGCCCAACATCA       TCCACGGAGTTCTGGGTTCC
  33    VDR      ss12568583        G-*A*              5\' UTR                   28.1               CAGCATGCCTGTCCTCAGC              CCAGTACTGCCAGCTCCCA
  34    VDR      ss12568581        C-*T*              Exon 2      4,818         37.3               TGGCCCTGGCACTGACTC               GGCACGTTCCGGTCAAAGTC
  35    VDR      ss12568582        C-*T*              Exon 4      21,590        0.0                GGACAGTCTGCGGCCCA                CCCTACTCCCTGGGCCC
  36    VDR      ss12568610        G-*A*              Intron 8    11,470        41.9               GTGCCCCTCACTGCCCTTA              CCTCAAATAACAGGAATGTTGAGCCCA
  37    VDR      ss12568608        T-*C*              Exon 9      1,078         40.8               GGGCCAGGCAGTGGTATCAC             AGGTCGGCTAGCTTCTGGATCA

a: Minor alleles are given in italic. b: Distance from the previous SNP within each gene in the unit of bp. c: Frequency of minor allele

###### 

Number of main haplotypes observed within genes compared to the number of possible haplotypes and yin yang haplotype distribution

  Gene     Chromosome location   No. of SNPs   Kb spanned   SNP density (kb/SNP)   Observed No. of haplotypes^a^   Expected No. of haplotypes   Yin Yang haplotypes^b^
  -------- --------------------- ------------- ------------ ---------------------- ------------------------------- ---------------------------- ------------------------
  ApoE     19q13.2               4             3            0.75                   6                               16                           GATC, CGTC
  COL1A1   17q21.3-q22           3             16           5.33                   4                               8                            GGG, GTG
  ER-α     6q25.1                7             291          41.57                  20                              128                          TCGCGGG, CTGCGGG
  LEPR     1p31.2                3             66           22                     7                               8                            GCG, GGA
  PTHR1    3p22-p21.1            4             9            2.25                   7                               16                           GTAA, ACGC
  TGF-β1   19q13.1               3             22           7.33                   4                               8                            C+C, T+C-
  UCP3     11q13.4               3             5            1.67                   4                               8                            TCT, CTC
  VDR      12q12-14              4             39           9.75                   12                              16                           GTGT, GTAC

a: Only haplotypes with frequencies more than 1% were included \[14\] b: For the PTHR1 and UCP3, Yin yang haplotypes were presented. For the other six genes, the two most common haplotypes were presented. The haplotypes were reconstructed based on the SNPs in the order from 5\' to 3\' on the chromosome within each gene.

The yin yang haplotypes are defined as two high-frequency haplotypes composed of completely mismatching SNP alleles, i.e., nucleotides differ at every SNP in the haplotype pair \[[@B15]\]. We detected such haplotype phenomenon in two of the eight studied genes (Table [2](#T2){ref-type="table"}). In the PTHR1 gene, one pair of yin yang haplotypes, GTAA and ACGG (in the order of SNP20-21-22-23), was observed with frequencies of 34.2% and 52.6%, respectively. A pair of yin yang haplotypes, TCT and CTC (in the order of SNP28-30-31), was also observed in the UCP3 gene with frequencies of 23.5% and 40.5%, respectively.

LD analysis
-----------

In this study, we used two most common LD measures, D\' and r^2^, to determine the extent of LD in the genes (Figure [1](#F1){ref-type="fig"}). The average of D\' values within the eight genes was 0.475 ± 0.325 (±SD) with the range of 0.020--1.000, whereas the r^2^was 0.158 ± 0.255 (±SD), which ranged from 0.000 to 0.883. Until now, there was no unified standard for meaningful LD between a marker and a functional mutation. Although we do not know whether any of our studied SNPs is functional for osteoporosis and/or obesity, the knowledge of LD patterns revealed through them is useful in inferring effective intermarker distance. When a criterion of D\' \> 0.33 \[[@B4],[@B16]\] was used as a meaningful LD, 58.8% (30/51) of the SNP pairs met this criterion with the intermarker physical distance ranging from 138 bp (SNP3-SNP4) to \~122 kb (SNP12-SNP14). If we considered D\' = 0.7 as a limit for useful LD \[[@B17]\], only 33.3% (17/51 SNP pairs) were \"useful\". If a value of r^2^\> 0.1 was applied as a criterion for meaningful LD \[[@B16],[@B18]\], 31.4% (16/51 SNP pairs) would be considered in \"useful\" LD. When we used both D\' \> 0.33 and r^2^\> 0.1 as a criterion for meaningful LD \[[@B4],[@B16],[@B18]\], these 16 pairs still fell below this threshold. Such \"useful\" LD was relatively common in a pair-wise physical distance smaller than 8.6 kb, though it was detectable at the distance of 83 kb (SNP13-SNP14).

![An exponential decay function was employed to fit the relationship between LD and the physical distance between SNP markers within each gene (SigmaPlot 2000, SPSS Inc., Chicago, IL). X-axis is the physical distance in the unit of base pair.](1471-2156-5-11-1){#F1}

From Figure [1](#F1){ref-type="fig"}, the distribution of LD versus physical distance was irregular; however, a decay of LD with increasing distance was still evident. The Spearman correlation coefficient between D\' and the distance was -0.70 (*P*\< 0.01). The correlation coefficient was -0.49 (*P*\< 0.01) when LD was quantified by r^2^. Similar relationship was observed between LD measures and ln(distance), in which the correlation coefficient was -0.68 and -0.47 for D\' and r^2^, respectively. The D\'/ln(distance) was calculated for pair-wise SNPs within each gene. The average of D\'/ln(distance) varied a lot among these eight genes with the highest value of 0.085 in PTHR1 and the lowest value of 0.001 in TGF-β1. The Spearman correlation coefficient between the two LD measures was 0.81 (*P*\< 0.01).

Discussion
==========

Determining the haplotype and LD characteristics of candidate genes and/or genomic regions has important implications for strategies of complex diseases gene mapping \[[@B19]\]. In the present study, we illustrated the haplotype distribution and LD patterns in eight candidate genes for two complex diseases, obesity and osteoporosis, in 1873 subjects from 405 Caucasian nuclear families.

In this study, the yin yang haplotype pairs, mismatching at every SNP, were observed in two genes, PTHR1 and UCP3, but not in the other six. There are several possible reasons for such differences among genes. Other things being the same, lower LD levels result in smaller yin yang haplotype size, the genomic span per yin yang haplotype region \[[@B15]\]. The different SNP density and LD patterns among genes may be partly responsible for the discrepancies about yin yang haplotypes among genes. Lower minor allele frequencies in some genes may be another reason since minor allele frequency ≥10% is a threshold for yin yang haplotype analysis \[[@B15]\]. Moreover, yin yang haplotypes were affected by the factors that might be different among genes, such as the mutation and recombination rates \[[@B15]\].

So far, LD was inferred either by using unrelated random sample or family data. The LD values evaluated from these two different data sets were correlated, but in some instances they were quite different. Family subjects contain more information than unrelated random individuals, and the inference of LD using family data is more accurate \[[@B4]\]. Sample size is another important factor influencing the accuracy of LD evaluation. Generally, larger sample size can minimize sampling error and produce more accurate evaluation of LD \[[@B20]\]. In this study, haplotypes were reconstructed based on the nuclear families in a larger sample rather than unrelated individuals as the other studies \[[@B12],[@B18],[@B21],[@B22]\]. This increased the precision of LD evaluation.

In the present study, two most common measurements of LD, D\' and r^2^, were used, both measurements varying between 0 and 1. According to their calculating formula \[[@B23]\], they are positively correlated, as observed in this study, but sometimes they are quite different. For example, D\' value for SNP6-SNP8 was 1.000, while the value for r^2^was only 0.004. Such a discrepancy between the two measures was also observed by Tiret et al \[[@B17]\]. One possible explanation for the discrepancy is that the rare allele frequency of SNP8 was very low, only 1.9%, and r^2^is more sensitive to allele frequencies than D\' \[[@B23]\].

Although a trend of decay of LD with increasing physical distance was observed in the present study, there was a great variation in LD with distance. For example, the physical distances for SNP33-SNP34 in VDR and SNP20-SNP21 in PTHR1 were both about 5 kb, however, the D\' values were 0.062 and 0.964, and the r^2^were 0.004 and 0.826, respectively. In the ER-α gene, the physical distance of SNP14-SNP15 was about 2.6 times that of SNP13-SNP14, while the D\' values were 0.675 and 0.028, and r^2^were 0.599 and 0.019, respectively. Such irregularity has been observed in the other studies \[[@B6],[@B17],[@B18],[@B24]\] and is expected, since LD is also affected by other factors, such as natural selection, the rates of recombination and mutation, and gene conversion \[[@B25]\].

Several limitations of this study should be acknowledged. Compared with some recent analyses \[[@B4],[@B14],[@B26]\], we only selected a limited number of SNPs in each gene, which may bring some difficulty to define the LD characteristics. Though 15-kb chromosome-wide resolution for LD pattern and haplotype structure study is acceptable but not ideal \[[@B27]\]. In addition, the yin yang haplotype analysis might be affected by the limited SNPs and genes examined. The SNPs were chosen based on the information from available literature and public databases rather than evenly distributed within gene. Another limitation is that this study was restricted to Caucasians of European descent, which limited the ability to perform cross-population comparisons for yin yang haplotype coverage and haplotype diversities etc. Since genetic diversity and LD extent differ between populations, studying contrasted populations is informative. However, if the purpose is to provide guidelines for the design of association studies in a given population, information drawn from that population should be preferable \[[@B5]\], especially because Caucasians are more susceptible to osteoporosis and obesity compared with other populations \[[@B28],[@B29]\].

In conclusion, the haplotype distribution was different among the eight studied candidate genes for osteoporosis and/or obesity. The LD characteristics were different between genes or even at different regions within gene, though LD decays with the increase of physical distance. The differences in haplotype distributions and LD patterns among genes underscore the importance of characterizing each locus of interest prior to association studies.

Methods
=======

Subjects
--------

The study subjects came from the ongoing genetic studies of osteoporosis and obesity that have been approved by the Creighton University Institutional Review Board. All subjects were Caucasians of European origin. We have recruited 405 nuclear families composed of 1,873 healthy individuals, including 840 parents, 744 daughters and 389 sons. All individuals signed informed-consent documents before entering the project.

Genotyping
----------

After searching public SNP databases, such as dbSNP <http://www.ncbi.nlm.nih.gov/SNP/>, and available literature, 37 SNPs in the eight candidate genes for obesity and/or osteoporosis were chosen. The selection criteria were as follows: 1) functional relevance and importance; 2) position in or around the gene; and 3) their use in previous genetic studies. Information about the 37 SNPs is presented in Table [1](#T1){ref-type="table"}. The genotyping procedure for all SNPs was similar, involving polymerase chain reaction (PCR) and invader assay reaction (Third Wave Technology, Madison, WI). PCR was performed in a 10 μl reaction mixture. The sequences of the PCR primers for all 37 SNPs are presented in Table [1](#T1){ref-type="table"}. After amplification, an invader reaction was performed in a 7.5 μl reaction volume. The genotype for every sample was called according to the ratio of the fluorescence intensity of the two dyes, which was read using a Cytofluor 4000 multi-well plate reader (Applied Biosystems, Foster City, CA). Program PedCheck <http://watson.hgen.pitt.edu/register/soft_doc.html> was employed to verify Mendelian inheritance of all marker alleles within each family \[[@B30]\].

We initially genotyped all 37 SNPs in a random sample of 190 to 380 subjects. The minor allele frequency of six SNPs was found less than 1.0%. Because the precision and variance of LD estimates suffer from low allele frequencies \[[@B6]\], these six SNPs were excluded from further genotyping and data analysis. Finally, 31 SNPs were analyzed in this study. Among them, 14 were located in exons, 12 in introns, and 5 in untranslated regions. SNP23 in the TGF-β1 gene is an insertion/deletion polymorphism of a cytosine (+/- C) and the other 30 SNPs are nucleotide substitutions, including 25 transitions and 5 transversions. These 31 SNPs totally spanned \~451 kb. The average intermarker distance was 63 kb (ranging from 138 bp to 291 kb).

Statistical analysis
--------------------

Allele frequencies of each SNP were estimated in 1,873 subjects using a maximum likelihood method implemented in the program SOLAR which is available at <http://www.sfbr.org/sfbr/public/software/solar>. The haplotypes of each gene for all subjects were reconstructed using the program Genehunter version 2.1 <http://www.hgmp.mrc.ac.uk/Registered/Option/genehunter.html>. Genehunter extracts complete multipoint inheritance information to infer maximum likelihood haplotypes for all individuals in nuclear families \[[@B31]\]. Haplotype frequencies were estimated from the unrelated subjects (parents of the nuclear families).

Two normalized measures, *D*\' and *r*^2^, were used to characterize the LD patterns within the studied candidate gene. Pair-wise *D*\' values are computed as: *D*\' = *D*/*D*~max~, *D*~max~= min(*f*~1+~*f*~+2~, *f*~+1~*f*~2+~) when *D*\> 0, and *D*~max~= min(*f*~1+~*f*~+1~, *f*~+2~*f*~2+~) when *D*\< 0, where *f*\'s are sample estimates of SNP frequencies \[[@B32]\]. r^2^is quantified as *r*^2^= (*f*~11~*f*~22~- *f*~12~*f*~21~)^2^/\[(*f*~11~+ *f*~12~)(*f*~21~+ *f*~22~)(*f*~11~+ *f*~21~)(*f*~12~+ *f*~22~)\], where *f*\'s are sample estimates of haplotype frequencies \[[@B23]\]. An exponential decay function was employed to fit the relationship between LD (both D\' and r^2^) and the physical distance between SNP markers within each gene (SigmaPlot 2000, SPSS Inc., Chicago, IL). To quantify the relationship between *D*\' and *r*^2^both as index of LD, correlation coefficient between them was calculated using SPSS software.
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